Pathogenic diversity among Chlamydia trachomatis ocular strains in nonhuman primates is affected by subtle genomic variations

Journal of Infectious Diseases

Volumn 197, Issue 3, 2008, Pages 449-456

  Kari, Laszlo ^a   Whitmire, William M ^a   Carlson, John H ^a   Crane, Deborah D ^a   Reveneau, Nathalie ^a,f   Nelson, David E ^b   Mabey, David C W ^c   Bailey, Robin L ^c   Holland, Martin J ^c,d   McClarty, Grant ^e   Caldwell, Harlan D ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b INDIANA UNIVERSITY   (United States)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^e UNIVERSITY OF MANITOBA   (Canada)

^f Sanofi Pasteur   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; OUTER MEMBRANE PROTEIN A;

ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CHLAMYDIA TRACHOMATIS; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; EYE INFECTION; GENE; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC VARIABILITY; GENOME ANALYSIS; GROWTH RATE; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MICROARRAY ANALYSIS; MICROBIAL DIVERSITY; MORPHOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENICITY; PRIMATE; PRIORITY JOURNAL; SEROTYPE; TRACHOMA;

ANIMALS; CHLAMYDIA TRACHOMATIS; GENOME, BACTERIAL; HELA CELLS; HUMANS; MACACA FASCICULARIS; MALE; POLYMORPHISM, GENETIC; PRIMATES; TRACHOMA; VARIATION (GENETICS);

EID: 39349090644     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/525285     Document Type: Article

References (46)

1. Resnikoff S, Pascolini D, Etya'ale D, et al. Global data on visual impairment in the year 2002. Bull World Health Organ 2004; 82:844-51.
2. Vogel G. Infectious diseases: tackling neglected diseases could offer more bang for the buck. Science 2006; 311:592-3.
3. Bowman RJ, Jatta B, Cham B, et al. Natural history of trachomatous scarring in the Gambia: results of a 12-year longitudinal follow-up. Ophthalmology 2001; 108:2219-24.
4. West SK, Munoz B, Mkocha H, Hsieh YH, Lynch MC. Progression of active trachoma to scarring in a cohort of Tanzanian children. Ophthalmic Epidemiol 2001; 8:137-44.
5. Schachter J. Chlamydial infections (first of three parts). N Engl J Med 1978; 298:428-34.
6. Schachter J. Chlamydial infections (third of three parts). N Engl J Med 1978; 298:540-9.
7. Conway DJ, Holland MJ, Campbell AE, et al. HLA class I and II polymorphisms and trachomatous scarring in a Chlamydia trachomatis-endemic population. J Infect Dis 1996; 174:643-6.
8. White AG, Bogh J, Leheny W, et al. HLA antigens in Omanis with blinding trachoma: markers for disease susceptibility and resistance. Br J Ophthalmol 1997; 81:431-4.
9. Natividad A, Wilson J, Koch O, et al. Risk of trachomatous scarring and trichiasis in Gambians varies with SNP haplotypes at the interferon-gamma and interleukin-10 loci. Genes Immun 2005; 6:332-40.
10. Natividad A, Cook G, Holland MJ, et al. A coding polymorphism in matrix metalloproteinase 9 reduces risk of scarring sequelae of ocular Chlamydia trachomatis infection. BMC Med Genet 2006; 7:40.
11. Natividad A, Hanchard N, Holland MJ, et al. Genetic variation at the TNF locus and the risk of severe sequelae of ocular Chlamydia trachomatis infection in Gambians. Genes Immun 2007; 8:288-95.
12. Caldwell HD, Kromhout J, Schachter J. Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis. Infect Immun 1981; 31:1161-76.
13. Wang SP, Grayston JT. Serotyping of Chlamydia trachomatis by indirect fluorescent-antibody staining of inclusions in cell culture with monoclonal antibodies. J Clin Microbiol 1991; 29:1295-8.
14. Yuan Y, Zhang Y-X, Watkins NG, Caldwell HD. Nucleotide and deduced amino acid sequences for the four variable domains of the major outer membrane proteins of the 15 Chlamydia trachomatis serovars. Infect Immun 1989; 57:1040-9.
15. Zhang J, Leitman T, Olinger L, Mio Y, Stephens RS. Genetic diversity of Chlamydia trachomatis and the prevalence of trachoma. Pediatr Infect Dis J 2004; 23:217-20.
16. Bailey RL, Hayes L, Pickett M, Whittle HC, Ward ME, Mabey DC. Molecular epidemiology of trachoma in a Gambian village. Br J Ophthalmol 1994; 78:813-17.
17. Nichols RL, von Fritzinger K, McComb DE. Epidemiological data derived from immunotyping of 338 trachoma strains isolated from children in Saudi Arabia. In: Nichols RL, ed. Trachoma and related disorders caused by chlamydial agents. Amsterdam: Excerpta Medica, 1971: 337-57.
18. Millman K, Black CM, Stamm WE, et al. Population-based genetic epidemiologic analysis of Chlamydia trachomatis serotypes and lack of association between ompA polymorphisms and clinical phenotypes. Microbes Infect 2006; 8:604-11.
19. Matsumoto A, Izutsu H, Miyashita N, Ohuchi M. Plaque formation by and plaque cloning of Chlamydia trachomatis biovar trachoma. J Clin Microbiol 1998; 36:3013-9.
20. Carlson JH, Porcella SF, McClarty G, Caldwell HD. Comparative genomic analysis of Chlamydia trachomatis oculotropic and genitotropic strains. Infect Immun 2005; 73:6407-18.
21. Albert TJ, Dailidiene D, Dailide G, et al. Mutation discovery in bacterial genomes: metronidazole resistance in Helicobacter pylori. Nat Methods 2005; 2:951-3.
22. Carlson JH, Hughes S, Hogan D, et al. Polymorphisms in the Chlamydia trachomatis cytotoxin locus associated with ocular and genital isolates. Infect Immun 2004; 72:7063-72.
23. Committee on the Care and Use of Laboratory Animals of the Institute of Laboratory Animals Resources Commission of Life Sciences, National Research Council. Guide for the care and use of laboratory animals. Washington, DC: National Academy Press, 1996.
24. Stephens RS, Kalman S, Lammel C, et al. Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis. Science 1998; 282:754-9.
25. Caldwell HD, Wood H, Crane D, et al. Polymorphisms in Chlamydia trachomatis tryptophan synthase genes differentiate between genital and ocular isolates. J Clin Invest 2003; 111:1757-69.
26. Takemoto KK. Plaque mutants of animal viruses. Prog Med Virol 1966; 8:314-48.
27. Beatty WL, Belanger TA, Desai AA, Morrison RP, Byrne GI. Tryptophan depletion as a mechanism of gamma interferon-mediated chlamydial persistence. Infect Immun 1994; 62:3705-11.
28. Perry LL, Feilzer K, Caldwell HD. Immunity to Chlamydia trachomatis is mediated by T helper 1 cells through IFN-γ-dependent and -independent pathways. J Immunol 1997; 158:3344-52.
29. Raulston JE. Response of Chlamydia trachomatis serovar E to iron restriction in vitro and evidence for iron-regulated chlamydial proteins. Infect Immun 1997; 65:4539-47.
30. Shtrichman R, Samuel CE. The role of gamma interferon in antimicrobial immunity. Curr Opin Microbiol 2001; 4:251-9.
31. Taylor HR, Prendergast RA, Dawson CR, Schachter J, Silverstein AM. An animal model for cicatrizing trachoma. Invest Ophthalmol Vis Sci 1981; 21:422-33.
32. Taylor HR, Johnson SL, Prendergast RA, Schachter J, Dawson CR, Silverstein AM. An animal model of trachoma. II. The importance of repeated reinfection. Invest Ophthalmol Vis Sci 1982; 23:507-15.
33. Holland MJ, Bailey RL, Conway DJ, et al. T helper type-1 (Th1)/Th2 profiles of peripheral blood mononuclear cells (PBMC): responses to antigens of Chlamydia trachomatis in subjects with severe trachomatous scarring. Clin Exp Immunol 1996; 105:429-35.
34. Gomes JP, Nunes A, Bruno WJ, Borrego MJ, Florindo C, Dean D. Polymorphisms in the nine polymorphic membrane proteins of Chlamydia trachomatis across all serovars: evidence for serovar Da recombination and correlation with tissue tropism. J Bacteriol 2006; 188:275-86.
35. Klint M, Fuxelius HH, Goldkuhl RR, et al. High-resolution genotyping of Chlamydia trachomatis strains by multilocus sequence analysis. J Clin Microbiol 2007; 45:1410-4.
36. Brickman TJ, Barry CED, Hackstadt T. Molecular cloning and expression of hctB encoding a strain-variant chlamydial histone-like protein with DNA-binding activity. J Bacteriol 1993; 175:4274-81.
37. Belland RJ, Zhong G, Crane DD, et al. Genomic transcriptional profiling of the developmental cycle of Chlamydia trachomatis. Proc Natl Acad Sci USA 2003; 100:8478-83.
38. Hwang YW, Sanchez A, Miller DL. Mutagenesis of bacterial elongation factor Tu at lysine 136: a conserved amino acid in GTP regulatory proteins. J Biol Chem 1989; 264:8304-9.
39. Zhang H, Tao J, Zhou M, et al. Elongation factor Ts of Chlamydia trachomatis: structure of the gene and properties of the protein. Arch Biochem Biophys 1997; 344:43-52.
40. Fehlner-Gardiner C, Roshick C, Carlson JH, et al. Molecular basis defining human Chlamydia trachomatis tissue tropism: a possible role for tryptophan synthase. J Biol Chem 2002; 277:26893-903.
41. Frazzon J, Dean DR. Formation of iron-sulfur clusters in bacteria: an emerging field in bioinorganic chemistry. Curr Opin Chem Biol 2003; 7:166 -73.
42. Outten FW, Djaman O, Storz G. A suf operon requirement for Fe-S cluster assembly during iron starvation in Escherichia coli. Mol Microbiol 2004; 52:861-72.
43. Morrison RP. Differential sensitivities of Chlamydia trachomatis strains to inhibitory effects of gamma interferon. Infect Immun 2000; 68:6038-40.
44. Nelson DE, Crane DD, Taylor LD, Dorward DW, Goheen MM, Caldwell HD. inhibition of chlamydiae by primary alcohols correlates with the strain-specific complement of plasticity zone phospholipase D genes. Infect Immun 2006; 74:73-80.
45. Clifton DR, Fields KA, Grieshaber S, et al. A chlamydial type III translocated protein is tyrosine phosphorylated at the site of entry and associated with recruitment of actin. Proc Natl Acad Sci USA 2004; 101:10166-71.
46. Jewett TJ, Fischer ER, Mead DJ, Hackstadt T. Chlamydial TARP is a bacterial nucleator of actin. Proc Natl Acad Sci USA 2006; 103:15599-604.